V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290005056 | 290003692 | 1.78 | 75.1 | Curative (C) | 2016-03-19 | 2016-03-19 | CAPECITABINE + RT | N | N | 290022274 | CARBOPLATIN + CETUXIMAB |
| 290005057 | 290003692 | 0 | 0 | null | null | 2015-04-06 | Capecitabine + Cisplatin + RT | null | null | 290022274 | IRINOTECAN + MDG |
| 290005058 | 290003693 | 1.68 | 50 | Palliative (P) | 2018-02-21 | 2018-02-21 | LANREOTIDE | N | N | 290022276 | CARBOPLATIN |
| 290005059 | 290003694 | 1.53 | 60.5 | Neo-adjuvant (N) | 2015-08-15 | 2015-08-15 | CARBOPLATIN + RT | 02 | N | 290022278 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 290005060 | 290006603 | 1.78 | 60 | Palliative (P) | 2017-11-28 | 2018-01-02 | Cetuximab + Radiotherapy Maint | N | N | 290022279 | CISPLATIN + FLUOROURACIL |
| 290005061 | 290006603 | 1.62 | 71.3 | Adjuvant (A) | 2013-12-08 | 2013-12-11 | OCTREOTIDE | 02 | null | 290022279 | NOT MATCHED |
| 290005062 | 290006603 | 1.75 | 59.7 | Palliative (P) | 2017-01-16 | 2017-02-04 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 290022279 | ECARBOF |
| 290005063 | 290003695 | null | 52.4 | Neo-adjuvant (N) | 2016-05-19 | 2016-05-23 | Capecitabine 35days + RT | null | N | 290022283 | IRINOTECAN + MDG |
| 290005064 | 290003696 | 0 | 64.9 | Palliative (P) | 2017-09-29 | 2017-10-13 | Cisplatin +Fluorouracil (2 wk) | N | N | 290022285 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 290005065 | 290003696 | 1.57 | 55 | Palliative (P) | 2017-10-07 | 2017-10-07 | CISPLATIN + FLUOROURACIL | 02 | N | 290022285 | EOX |
| 290005066 | 290003697 | 0 | 63 | Palliative (P) | 2017-01-23 | 2017-02-11 | Capecitabine | 02 | null | 290022288 | CISPLATIN + FLUOROURACIL |
| 290005067 | 290003698 | 1.76 | 61 | null | 2018-01-23 | 2018-01-23 | Capecitabine 42days + RT | 1 | N | 290022289 | CAPECITABINE |
| 290005068 | 290003699 | 1.6 | 80 | null | null | 2017-12-10 | LANREOTIDE | null | null | 290022290 | CARBOPLATIN |
| 290005069 | 290003700 | 1.62 | 85 | Palliative (P) | 2017-03-02 | 2017-03-02 | EOX | 2 | N | 290022292 | IRINOTECAN + MDG |
| 290005070 | 290003701 | 1.72 | 98.4 | Not known (9) | 2015-05-31 | 2015-06-20 | Fluorouracil 96hr infusion+R(4g/m2) | 02 | Y | 290022293 | CAPECITABINE |
| 290005071 | 290003701 | 1.74 | 83.5 | null | 2016-12-19 | 2017-01-08 | Trial Unspecified | N | Y | 290022293 | CAPECITABINE + CARBOPLATIN |
| 290005072 | 290003702 | null | null | null | 2017-08-29 | 2017-09-01 | Capecitabine + Cisplatin | N | null | 290022295 | CAPECITABINE |
| 290005073 | 290003703 | 1.86 | 98.4 | Palliative (P) | null | 2013-08-05 | Capecitabine | N | N | 290022296 | CAPECITABINE |
| 290005074 | 290003703 | 1.63 | 63 | null | 2015-03-13 | 2015-03-16 | ECX | 02 | null | 290022296 | CARBO + FLUOROURACIL |
| 290005075 | 290003704 | 1.58 | 58 | Adjuvant (A) | 2016-06-15 | 2016-06-21 | Carboplatin + Pemetrexed | 2 | N | 290022300 | CETUXIMAB + RT |
| 290005076 | 290003704 | 0 | 80 | Neo-adjuvant (N) | 2016-11-18 | 2016-11-21 | Capecitabine 35days + RT | N | N | 290022300 | OCTREOTIDE |
| 290005077 | 290003705 | 1.74 | 70.7 | null | 2016-07-28 | 2016-07-28 | Bevacizumab+Carbo+Pacliaxel | N | N | 290022306 | CARBOPLATIN + RT |
| 290005078 | 290003706 | null | 79.5 | 5 | 2017-03-25 | 2017-03-28 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 290022307 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005079 | 290003707 | 1.66 | 58.1 | Palliative (P) | 2014-10-19 | 2014-10-19 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 290022310 | CAPECITABINE + CISPLATIN |
| 290005080 | 290003708 | 1.73 | 77.8 | Palliative (P) | 2017-01-23 | 2017-01-23 | Carboplatin + Cetux + FU (Cycle 1) | 02 | N | 290022311 | LANREOTIDE |
| 290005081 | 290003709 | 1.63 | 77.7 | Neo-adjuvant (N) | 2017-11-17 | 2017-11-18 | Capecitabine 35days + RT | N | N | 290022312 | CAPECITABINE + RT |
| 290005082 | 290003710 | null | 67.4 | Neo-adjuvant (N) | 2013-07-12 | 2013-07-12 | PACLITAXEL + TRASTUZUMAB | null | N | 290022313 | TRIAL |
| 290005083 | 290003711 | 1.69 | 124 | Adjuvant (A) | 2016-03-12 | 2016-03-26 | CAPECITABINE + RT | N | N | 290022316 | CISPLATIN + ETOPOSIDE |
| 290005084 | 290003712 | 1.4 | 69 | null | 2016-10-12 | 2016-10-16 | CARBOPLATIN | 01 | N | 290022318 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005085 | 290003713 | null | 91.5 | Neo-adjuvant (N) | 2014-02-03 | 2014-02-03 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 290022320 | CARBOPLATIN + PEMETREXED |
| 290005086 | 290003714 | 1.75 | 95.7 | Curative (C) | 2013-06-28 | 2013-07-24 | Trial Unspecified | N | Y | 290022321 | CARBOPLATIN |
| 290005087 | 290003715 | 1.81 | 82.5 | Palliative (P) | 2016-04-27 | 2016-05-12 | Trial Unspecified | N | N | 290022322 | BORTEZOMIB + THALIDOMIDE |
| 290005088 | 290003716 | 1.8 | 60.5 | null | 2015-02-25 | 2015-02-25 | LANREOTIDE | 02 | N | 290022326 | EC + PACLITAXEL |
| 290005089 | 290003717 | null | null | Curative (C) | 2015-11-10 | 2015-11-14 | OCTREOTIDE | 02 | Y | 290022327 | OCTREOTIDE |
| 290005090 | 290003717 | 1.58 | 50.4 | Disease modification (D) | 2016-05-26 | 2016-05-26 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 290022327 | PEMBROLIZUMAB |
| 290005091 | 290003718 | null | null | Curative (C) | 2015-05-30 | 2015-06-19 | OCTREOTIDE | N | N | 290022331 | ECX |
| 290005092 | 290003719 | 1.73 | 84.9 | Neo-adjuvant (N) | 2014-10-29 | 2014-10-29 | Capecitabine | null | N | 290022333 | NOT MATCHED |
| 290005093 | 290003720 | 1.77 | null | Curative (C) | 2013-11-25 | 2013-11-30 | OCTREOTIDE | Y | Y | 290022338 | LANREOTIDE |
| 290005094 | 290003721 | 1.76 | 79.2 | Curative (C) | 2017-12-24 | 2017-12-25 | Capecitabine + Cisplatin | 02 | N | 290022340 | CAPECITABINE + CISPLATIN |
| 290005095 | 290006609 | 1.6 | 91.3 | Palliative (P) | 2014-06-03 | 2014-06-18 | CETUXIMAB + RT | N | N | 290022345 | CISPLATIN + ETOPOSIDE |
| 290005096 | 290003722 | 1.8 | 91.5 | Palliative (P) | 2017-09-25 | 2017-09-25 | Carboplatin 21day + Paclitaxel 7day | 02 | null | 290022347 | CAPECITABINE + RT |
| 290005097 | 290003723 | 1.64 | 65 | Neo-adjuvant (N) | 2017-03-15 | 2017-04-11 | FLUOROURACIL | 02 | N | 290022348 | LANREOTIDE |
| 290005098 | 290003724 | null | 121.6 | Palliative (P) | null | 2013-09-13 | Fluorouracil 96hr infusion+R(4g/m2) | N | N | 290022349 | LANREOTIDE |
| 290005099 | 290003725 | 1.62 | null | Palliative (P) | 2013-08-06 | 2013-09-04 | Cisplatin +Fluorouracil (3 wk) | N | N | 290022352 | CARBOPLATIN |
| 290005100 | 290003726 | 1.7 | null | Palliative (P) | null | 2017-11-02 | LANREOTIDE | N | Y | 290022355 | CISPLATIN + FLUOROURACIL |
| 290005101 | 290003727 | 1.81 | 73 | Palliative (P) | 2015-08-09 | 2015-08-09 | EOX | 02 | N | 290022356 | CARBOPLATIN + PACLITAXEL |
| 290005102 | 290003728 | null | 80.2 | Palliative (P) | 2016-06-30 | 2016-07-17 | Cetuximab + Radiotherapy Load | null | N | 290022358 | GEMCARBO |
| 290005103 | 290003729 | 1.47 | 71.25 | Adjuvant (A) | null | 2013-08-21 | Capecitabine | N | N | 290022361 | CARBOPLATIN + ETOPOSIDE |
| 290005104 | 290003730 | null | 46 | Palliative (P) | 2015-07-01 | 2015-07-01 | Capecitabine | null | null | 290022363 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 290005105 | 290003730 | null | 46 | Disease modification (D) | 2015-06-03 | 2015-06-25 | INTERFERON | N | N | 290022363 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |